MedPath

Dimenydrinate vs Ondansetron for PONV (DONV)

Not Applicable
Completed
Conditions
PONV in Laparoscopic Cholocystectomies
Interventions
Registration Number
NCT05590936
Lead Sponsor
University of Thessaly
Brief Summary

This study will investigate the impact of dimenydrinate (H1-receptor antagonist) versus ondansetron (HT3-receptor antagonist) in postoperative nausea and vomiting, in surgery-related preoperative stress and in the incidence of postoperative complications that could lengthen the LOS in PACU and/or the overall LOS.

Detailed Description

Dimenydrinate has been extensively used for motion sickness. However, as far as postoperative nausea and vomiting is concerned the results are still conflicting.

This study will investigate the impact of dimenydrinate (H1-receptor antagonist) versus ondansetron (HT3-receptor antagonist) in postoperative nausea and vomiting, in surgery-related preoperative stress and in the incidence of postoperative complications that could lengthen the LOS in PACU and/or the overall LOS.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
190
Inclusion Criteria
  • Age 18-75 years old
  • ASA PS I-III
  • Undergoing laparoscopic general surgery operations or laparoscopic gynecological operations
Exclusion Criteria
  • Refused to participate
  • Age other than 18-75 years old
  • Pregnant patients
  • Non-elective operations
  • Patients that are not able to receive p.os agents
  • Medical history of Brugada Sdr or Brugada-like/related ECG abnormalities
  • Long-Qt Sdr or concurrent use of medications that may cause long-QT ECG abnormalities
  • Medical or family history of psychosis
  • Allergy in dimenydrinate or in dimenydrinate drug versions
  • Perioperative use of dexamethasone

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
DimenydrinateDimenhydrinate TabletsPreoperative per os administration of 50 mg dimenydrinate
OndasentronOndansetron ivIntraoperative intravenous administration of 4 mg ondansetron
Primary Outcome Measures
NameTimeMethod
PONV24 hours postoperative

PONV recording in patients undergone laparoscopic cholocystectomy

Secondary Outcome Measures
NameTimeMethod
Awaken timeon extubation

time from anesthetic drug cessation until extubation

preoperative anxiety30 minutes before operation

preoperative anxiety recording in patients undergone laparoscopic cholocystectomy measured by one hundred points scale

Trial Locations

Locations (1)

University Hospital of Larisa, Department of Anesthesiology

🇬🇷

Larissa, Thessaly, Greece

© Copyright 2025. All Rights Reserved by MedPath